In depth Focus

Drug development In-Depth Focus 2025

Published: 19 September 2025

Share this post

1

From groundbreaking cell and gene therapies to cost-effective drug delivery innovations, Europe is emerging as a hub for life-changing therapies. Explore expert insights and innovative solutions shaping the pharmaceutical industry.

  • Alliance for impact – advancing CGT development in Europe
    Cell therapy expert Lindsay Davies, PhD, FHEA, discusses the key considerations for moving the needle to broader adoption of CGTs in Europe. She’ll address scalability considerations, the need for regulatory alignment across jurisdictions and the question of reimbursement.
  • Lipid-based solid-dose drug delivery: a low-cost alternative to enhancing dissolution and bioavailability of poorly soluble compounds
    Over 70% of new drug candidates struggle with poor water solubility, limiting their effectiveness. Lipid-based solid-dose formulations offer a simple, cost-effective way to enhance dissolution, improve bioavailability, and potentially reduce dosing.

Access exclusive insights in drug development in pharma – register now

Share via